Email this article 
COVID-19 Vaccine Priority for People With Neurologic and Rare Diseases
Gerald Pfeffer
, Sarah Jacob, Jeffrey Preston
, Sarah Jacob, Jeffrey PrestonAbstract
N/A
J Neurol Res. 2021;11(1-2):1-4
doi: https://doi.org/10.14740/jnr665
J Neurol Res. 2021;11(1-2):1-4
doi: https://doi.org/10.14740/jnr665
Keywords
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); COVID-19; neurologic disease; rare disease; health equity; vaccine; public health policy